发明名称 |
Cytotoxic anti-LAG-3 monoclonal antibody and its use in the treatment or prevention of organ transplant rejection and autoimmune disease |
摘要 |
Cytotoxic anti-LAG-3 monoclonal antibodies or fragments thereof causing depletion of LAG-3+ activated T cells are described, as are related pharmaceuticals and methods of treating. Also described are related nucleic acid and protein sequences. |
申请公布号 |
US9244059(B2) |
申请公布日期 |
2016.01.26 |
申请号 |
US201012823795 |
申请日期 |
2010.06.25 |
申请人 |
Immutep Parc Club Orsay;Inserm—Institut National De La Sante Et De La Recherche Medicale |
发明人 |
Triebel Frederic;Vanhove Bernard;Haudebourg Thomas |
分类号 |
G01N33/50;C07K16/28;A61K39/00 |
主分类号 |
G01N33/50 |
代理机构 |
|
代理人 |
Tomaska Margaret M.;Gimmi Edward R. |
主权项 |
1. Monoclonal antibody IMP731 or a biologically active fragment thereof, wherein the monoclonal antibody IMP731 or the biologically active fragment thereof comprises a light chain kappa region as set forth in amino acids 21 to 240 of SEQ ID NO:13 and a heavy chain gamma region as set forth in amino acids 20 to 465 of SEQ ID NO:16, and wherein the monoclonal antibody IMP731 or biologically active fragment thereof comprises an Fc fragment from human IgGl, human IgM, or mouse IgG2a and an Fab fragment that binds LaG-3 protein, and wherein said moloclonal antibody IMP731 or biologically active fragment thereof is capable of depleting LAG-3+ activated T cells in a complement dependent cytotoxicity (CDC) assay, or in an antibody-dependent cell cytotoxicity (ADCC) assay, or both. |
地址 |
Orsay FR |